Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jacqueline Galeas

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Cell|November 23, 2015
K-Ras Promotes Tumorigenicity through Suppression of Non-canonical Wnt SignalingMan-Tzu Wang, Matthew Holderfield, Jacqueline Galeas, et al.
Cancer Research|May 16, 2015
Enhanced MET Translation and Signaling Sustains K-Ras-Driven Proliferation under Anchorage-Independent Growth ConditionsSaori Fujita-Sato, Jacqueline Galeas, Morgan Truitt, et al.
Nature Communications|July 13, 2019
Blockade of leukemia inhibitory factor as a therapeutic approach to KRAS driven pancreatic cancerMan-Tzu Wang, Nicole Fer, Jacqueline Galeas, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 17, 2015
Ras-GTP dimers activate the Mitogen-Activated Protein Kinase (MAPK) pathwayXiaolin Nan, Tanja M Tamgüney, Eric A Collisson, et al.
Science (New York, N.Y.)|March 16, 2019
RIT1 oncoproteins escape LZTR1-mediated proteolysisPau Castel, Alice Cheng, Antonio Cuevas-Navarro, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 31, 2021
UDP-glucose pyrophosphorylase 2, a regulator of glycogen synthesis and glycosylation, is critical for pancreatic cancer growthAndrew L Wolfe, Qingwen Zhou, Eneda Toska, et al.
Nature|November 2, 2017
Drug-tolerant persister cancer cells are vulnerable to GPX4 inhibitionMatthew J Hangauer, Vasanthi S Viswanathan, Matthew J Ryan, et al.
Nature Medicine|November 28, 2018
Aurora kinase A drives the evolution of resistance to third-generation EGFR inhibitors in lung cancerKhyati N Shah, Roma Bhatt, Julia Rotow, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Cell|November 23, 2015
K-Ras Promotes Tumorigenicity through Suppression of Non-canonical Wnt SignalingMan-Tzu Wang, Matthew Holderfield, Jacqueline Galeas, et al.
Cancer Research|May 16, 2015
Enhanced MET Translation and Signaling Sustains K-Ras-Driven Proliferation under Anchorage-Independent Growth ConditionsSaori Fujita-Sato, Jacqueline Galeas, Morgan Truitt, et al.
Nature Communications|July 13, 2019
Blockade of leukemia inhibitory factor as a therapeutic approach to KRAS driven pancreatic cancerMan-Tzu Wang, Nicole Fer, Jacqueline Galeas, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 17, 2015
Ras-GTP dimers activate the Mitogen-Activated Protein Kinase (MAPK) pathwayXiaolin Nan, Tanja M Tamgüney, Eric A Collisson, et al.
Science (New York, N.Y.)|March 16, 2019
RIT1 oncoproteins escape LZTR1-mediated proteolysisPau Castel, Alice Cheng, Antonio Cuevas-Navarro, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 31, 2021
UDP-glucose pyrophosphorylase 2, a regulator of glycogen synthesis and glycosylation, is critical for pancreatic cancer growthAndrew L Wolfe, Qingwen Zhou, Eneda Toska, et al.
Nature|November 2, 2017
Drug-tolerant persister cancer cells are vulnerable to GPX4 inhibitionMatthew J Hangauer, Vasanthi S Viswanathan, Matthew J Ryan, et al.
Nature Medicine|November 28, 2018
Aurora kinase A drives the evolution of resistance to third-generation EGFR inhibitors in lung cancerKhyati N Shah, Roma Bhatt, Julia Rotow, et al.
Pageof 1